Αρχική World News Men’s skin cancer rates increase by 50% over decade

Men’s skin cancer rates increase by 50% over decade

Patient gets moles checked by a doctor.

Over the last 10 years, melanoma skin cancer among men in the UK has increased by almost 50%.

Though rates for women have risen by 30% during the same time period, skin cancer is more common in men.

Men are also more likely to be diagnosed at a later stage than women, and skin cancers are often found on their torso – potentially explained by going shirtless. This can make it harder to spot unusual changes, particularly if they occur on their back. And sadly, the charity warns that the figures also show an 8% increase in death rates for men.

These figures are worrying – getting sunburnt just once every 2 years can triple the risk of skin cancer, so it’s important that everyone knows how to protect themselves. Seeking shade, covering up and applying sunscreen can help you to stay safe in the sun.

– Michelle Mitchell, Cancer Research UK’s chief executive

The new figures come months after a Cancer Research UK-funded study found a potential new link between higher testosterone level in the blood and an increased risk of melanoma in men.

The UK sun is just as strong as when abroad

As the weather in the UK begins to heat up and more people head outside, the charity is releasing these figures to encourage people to protect their skin from the sun, especially if they burn easily.

Michelle Mitchell, Cancer Research UK’s chief executive, said: “With staycations looking to be the norm for many this year, we mustn’t lose sight of the fact that UK sun can be every bit as strong as when we are abroad. The same advice still applies, and if something doesn’t feel right or you notice any changes to your skin, talk to your GP.”

‘Don’t delay contacting your GP’

Adrian Webb, aged 55, from Dudley, was first diagnosed with skin cancer in September 2012 after his wife, Michele, noticed a mole on his back had changed colour.

He had treatment including surgery and radiotherapy, but a year later was given the devastating news that his cancer had spread. He was told by his consultant that he may have just 12 months to live.

“I simply wouldn’t have consulted my doctor under my own steam, so I’m thankful my wife found the mole and potentially saved my life,” said Adrian.

Adrian underwent further treatment which ended in 2016, and his cancer has now been reduced to a trace.

“I couldn’t plan ahead for years, but now that I have been treatment free for over four years, I can start to look ahead again. Though I can’t change what happened, life for me now is so wonderful and I’m blessed with an amazing family.”

“I hope that my story can help prevent others from going through what I did. I would strongly encourage anyone who notices anything unusual about their skin not to delay contacting their GP.”

Staying safe in the sun

Despite rates being on the rise, almost 9 in 10 melanoma skin cancer cases are preventable.

While it’s easy to think that a tan is a sign of good health, there’s no such thing as a healthy tan from the sun or sunbeds. A tan is the body simply trying to protect itself from harmful rays.

In the UK, the sun’s rays are strongest between 11am and 3pm and can cause lasting damage to DNA in skins cells, even in cloudy weather.

Protect your skin:

  • Spending time in the shade, especially between 11am and 3pm in the UK.
  • Covering up with clothes, a wide-brimmed hat and UV protection sunglasses.
  • And using a sunscreen with at least SPF15 and 4 or 5 stars. Use it generously, reapply regularly and use together with shade and clothing.

And, although some people are at greater risk, experts warn that anyone can get sunburnt or develop skin cancer. People with naturally dark or brown skin burn less easily and have a lower risk of skin cancer, but when the sun is strong everyone should take the same precautions.

More on this topic



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

SABCS 2021: New Research and Updates in Breast Cancer Treatment and Side Effects

The 2021 San Antonio Breast Cancer Symposium (SABCS) was held from December 7 to 10 in San Antonio, Texas, and online. In this podcast,...

Cancer Research UK publishes gender and ethnicity pay gap reports

As part of Cancer Research UK’s ongoing commitment to improving the diversity of the organisation, the charity has today published its gender pay gap...

Can mRNA Vaccines Help Treat Cancer?

January 20, 2022, by NCI Staff A technician working on mRNA vaccine production. Credit: Image used with permission from BioNTech The coronavirus pandemic has thrown a spotlight...

A Phase III Study of Spartalizumab in Combination with Dabrafenib and Trametinib Did Not Meet Primary Endpoint in BRAF V600–Mutated Metastatic Melanoma

COMBI-i did not show a statistically significant difference in investigator-assessed progression-free survival (PFS) in the broad population of patients with BRAF V600–mutated metastatic melanoma treated in...

Wawa Employee Saves Life Of Customer Who Stopped Breathing After A Seizure

When 19-year-old John Wallop arrived for his 16-hour shift behind the deli counter at Wawa in Millville, New Jersey, he thought it would just...

New breast and lung cancer treatments approved in Scotland

A breast cancer cell 3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for use on the NHS in Scotland,...